Navigation Links
U-M's Yamashita named Howard Hughes Medical Institute investigator
Date:5/8/2013

ANN ARBORYukiko Yamashita of the University of Michigan's Life Sciences Institute is one of 27 biomedical researchers named today as Howard Hughes Medical Institute investigators.

HHMI provides flexible support on renewable five-year appointments to allow scientists to move their research in creative new directions. This year, 1,155 applicants applied to be investigators. Those selected represent 19 institutions from across the United States. Yamashita joins five other current U-M faculty membersincluding one from LSIon the list of HHMI investigators.

A central question fascinates Yamashita: When stem cells divide, what determines which daughter cell will remain a stem cell and which will differentiate into another tissue type?

Maintaining a balance between stem and differentiating cell populations during so-called asymmetrical cell division is critical because an excess of stem cells can lead to cancerous tumor growth, whereas too many differentiated cells can deplete the stem cell pool and reduce the capacity for tissue regeneration.

"I'm looking forward to designing and carrying out experiments that may yield new examples of asymmetrical stem cell division and perhaps finding unexpected links between those divisions and biological process," Yamashita said.

HHMI provides support for approximately 330 Hughes investigators and members of their research teams. Of the current investigators, 164 are members of the National Academy of Sciences and 15 are Nobel laureates.

"HHMI has a very simple mission," said HHMI President Robert Tjian. "We find the best original-thinking scientists and give them the resources to follow their instincts in discovering basic biological processes that may one day lead to better medical outcomes. This is a very talented group of scientists. And while we cannot predict where their research will take them, we're eager to help them move science forward."

Researchers with five to 15 years of experience as faculty members are eligible to apply to the investigator program. HHMI investigators receive salary, benefits, a research budget and funding for other expenses, including research space and the purchase of critical equipment. Investigator appointments may be renewed for additional five-year terms, contingent on a scientific review.

"When it comes to research, HHMI takes the long view," said Jack Dixon, vice president and chief scientific officer of HHMI and former director of the Life Sciences Institute at U-M. "You have to have that in basic research because you have no way of knowing if someone's research is going to be transformative 15 to 20 years down the line. We pick the best people we can find and then provide long-term, stable support so they can act quickly on their best research ideas."

During fiscal year 2012, HHMI made disbursements of $919 million, including $800 million for biomedical research and $119 million in grants to support science education and international science. The institute's endowment at the close of fiscal year 2012 stood at about $16.1 billion. HHMI's headquarters is in Chevy Chase, Md., just outside Washington, D.C.

Other HHMI investigators at U-M are James Bardwell, Arul Chinnaiyan, John Moran, Mercedes Pascual and the LSI's David Ginsburg. U-M's Ming Lei is an HHMI "early career scientist."

Yamashita is a faculty member of the Life Sciences Institute's Center for Stem Cell Biology, where her laboratory is located and all her research is conducted. She is also an assistant professor in the Department of Cell and Developmental Biology and the Cellular and Molecular Biology Program at the U-M Medical School.


'/>"/>

Contact: Laura J. Williams
laurajw@umich.edu
734-615-4862
University of Michigan
Source:Eurekalert

Related medicine news :

1. Edith Mitchell, M.D., FACP, named 2012 recipient of ASCO Humanitarian Award
2. Dr. William Oh named 2012 Legend of Neonatology
3. UCSC physicist Alexander Sher named Pew Scholar in the Biomedical Sciences
4. Old Bridge Sleep Center Named to Best of 2012 List
5. UMMS researcher Victor Ambros, Ph.D., named co-recipient of 2012 Janssen Award for Biomedical Research
6. Pittsburgh Cardiologist Named Physician of the Year by Pulmonary Hypertension Association
7. IVR Technology Group Named Platimum VAR by TSYS
8. New coral reef crustacean described and named after late reggae performer Bob Marley
9. UT Southwestern named the official health care team of the Dallas Stars
10. IHME professor named first health measurement winner of prestigious innovation award
11. College biology faculty named Leadership Fellows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... 17, 2017 , ... Cancer diagnostics workflow solution provider Inspirata, ... – 22 in San Francisco. As part of the Tri-Conference expo, which is ... solution, as well as its new precision medicine platform, “Crosswalk Insight: Oncology™.” , ...
(Date:2/17/2017)... ... February 17, 2017 , ... Top neuroendocrine cancer doctors, ... NET Foundation Summit from February 21 - 23 in Beaver Creek, CO. It was ... marks the Summit’s second year in Beaver Creek, hosting over 60 faculty members and ...
(Date:2/17/2017)... ... February 17, 2017 , ... Dillon ... to families and business owners in the greater Fort Lauderdale metropolitan region, is ... , For more than 30 years, LifeNet 4 Families has provided a broad ...
(Date:2/16/2017)... ... February 17, 2017 , ... For some cancer survivors, ... final treatments. Physician researchers at The Marcus Institute of Integrative Health at ... efficacy in reducing symptoms of traumatic stress in cancer patients and published ...
(Date:2/16/2017)... ... February 17, 2017 , ... The Price Agency, ... families and entrepreneurs in the Birmingham area, is announcing an ongoing charity event ... with her medically challenged son, Anius. , Anius is medically complex with diagnoses ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... , Feb. 17, 2017  Noble Capital Markets announced ... Pharma Inc. (Nasdaq: EPIX ). The report ... Kumar Raja , PhD. ESSA Pharmaceuticals is ... resistant prostate cancer (CRPC). Its lead compound EPI-506, is ... amino-terminal domain of the androgen receptor, thereby has potential ...
(Date:2/16/2017)... -- DaVita Inc. (NYSE: DVA ) today announced ... Net income attributable to DaVita Inc. for ... million, or $0.80 per share and $880 million, or $4.29 ... to DaVita Inc. for the quarter and year ended December ... million, or $0.98 per share, and $789 million, or $3.85 ...
(Date:2/16/2017)... -- Newly published research from the CVS Health (NYSE: ... private retailer can play in restricting access to tobacco ... in the American Journal of Public Health , ... all CVS Pharmacy stores reduced the number of cigarette ... impact on those who bought cigarettes exclusively at CVS ...
Breaking Medicine Technology: